ADCT R&D Expenses

Adc Therapeutics Sa · R&D Expenses

ADCT logo

ADCT R&D Expenses

Latest reported$17.37M
ADCT Quarterly R&D Expenses ($30.07M → $17.37M)
High-resolution chart · PNG

ADCT r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Adc Therapeutics Sa R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
17,366,000
19,877,000
18,184,000
26,803,000
30,090,000
28,928,000
27,101,000
32,502,000
24,295,000
25,735,000
30,330,000
28,440,000
31,342,000
38,375,000
48,733,000
41,676,000
48,537,000
48,952,000
42,492,000
36,805,000
39,533,000
39,172,000
48,552,000
32,155,000
25,950,000
35,375,000
30,424,000
30,541,000
21,760,000
23,286,000
29,090,000
29,090,000
30,066,500
30,066,500
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.